ARDX
ARDX
Positions held
Your positionsARDX isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | — | Enterprise value | — | Trailing P/E | — | Forward P/E | — |
| PEG | — | Price / book | — | Beta | — | Dividend yield | — |
| Revenue growth | — | Earnings growth | — | Gross margin | — | Operating margin | — |
| Profit margin | — | ROE | — | ROA | — | Debt / equity | — |
| Current ratio | — | Free cash flow | — | Analyst recommendation | — | Mean target | — |
| 52w high | — | 52w low | — |
Quarterly
No data yet.
Yearly (6y)
No data yet.
Headlines — positive tone
• [OK · fundamentals] Ardelyx (ARDX) Posts Record Revenue, Is The Stock Still 70% Undervalued?
• [OK · fundamentals] Ardelyx Inc (ARDX) (Q2 2026) Earnings Call Highlights: Record Revenue of $118M Driven by Strong ...
News
2026-10-07 · New Strong Sell Stocks for October 7th
2026-10-05 · Ardelyx to Present New Data on Hyperphosphatemia Management at ASN Kidney Week 2026
2026-09-30 · Ardelyx Earns Multiple Honors at the 2026 PM360 Trailblazer Awards
2026-09-21 · Ardelyx Targets $500M Revenue This Year, Profitability by 2027
2026-09-01 · Ardelyx to Participate in Upcoming Investor Conferences
2026-08-22 · Ardelyx (ARDX) Cuts Guidance On Payer Hurdles As Fair Value Debate Heats Up
2026-08-18 · Valeris Welcomes Patient Services Veteran Lauren Cole to Lead Commercial Strategy
2026-08-14 · Ardelyx (ARDX) Q2 2026 Earnings Call Transcript
2026-08-11 · Ardelyx (ARDX) Is Down 19.7% After Raising IBSRELA Revenue Guidance And Narrowing Losses
2026-08-07 · Ardelyx (ARDX) Posts Record Revenue, Is The Stock Still 70% Undervalued?
2026-08-07 · Wedbush Adjusts Price Target on Ardelyx to $9 From $19, Maintains Outperform Rating
Price (daily)
Full chart · RSI · MACD · patterns